Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS

NCT01995981 · clinicaltrials.gov ↗

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: Pazopanib

Sponsor

Radboud University Medical Center

Collaborators

[object Object]